Artiva Biotherapeutics (ARTV) Assets Average (2024 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Assets Average for 2 consecutive years, with $139.9 million as the latest value for Q4 2025.
- On a quarterly basis, Assets Average fell 35.7% to $139.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $139.9 million, a 35.7% decrease, with the full-year FY2025 number at $170.3 million, up 8.21% from a year prior.
- Assets Average was $139.9 million for Q4 2025 at Artiva Biotherapeutics, down from $159.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $217.6 million in Q4 2024 to a low of $139.9 million in Q4 2025.